RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 96 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $325,000 | -92.6% | 287,685 | -80.5% | 0.00% | -100.0% |
Q1 2022 | $4,411,000 | -4.0% | 1,475,083 | -14.9% | 0.00% | 0.0% |
Q4 2021 | $4,593,000 | -23.9% | 1,733,359 | +4.3% | 0.00% | -50.0% |
Q3 2021 | $6,033,000 | +91.8% | 1,661,958 | +129.3% | 0.00% | +100.0% |
Q2 2021 | $3,146,000 | -51.3% | 724,952 | -61.6% | 0.00% | -50.0% |
Q1 2021 | $6,459,000 | -9.8% | 1,888,645 | -7.7% | 0.00% | -33.3% |
Q4 2020 | $7,162,000 | +42.5% | 2,046,135 | -2.3% | 0.00% | +50.0% |
Q3 2020 | $5,025,000 | +32.1% | 2,094,228 | +0.7% | 0.00% | 0.0% |
Q2 2020 | $3,805,000 | +7.6% | 2,079,060 | -8.3% | 0.00% | 0.0% |
Q1 2020 | $3,536,000 | -32.2% | 2,266,710 | -6.9% | 0.00% | 0.0% |
Q4 2019 | $5,212,000 | +3.4% | 2,435,473 | -9.6% | 0.00% | 0.0% |
Q3 2019 | $5,040,000 | -27.8% | 2,695,069 | +0.8% | 0.00% | -33.3% |
Q2 2019 | $6,981,000 | +24.6% | 2,674,786 | +22.7% | 0.00% | +50.0% |
Q1 2019 | $5,602,000 | +49.4% | 2,179,943 | +33.7% | 0.00% | 0.0% |
Q4 2018 | $3,749,000 | +152.1% | 1,630,034 | +251.8% | 0.00% | +100.0% |
Q3 2018 | $1,487,000 | +118.7% | 463,340 | +141.3% | 0.00% | – |
Q1 2018 | $680,000 | -8.7% | 192,035 | 0.0% | 0.00% | – |
Q4 2017 | $745,000 | +38.5% | 192,035 | -9.4% | 0.00% | – |
Q3 2017 | $538,000 | -34.5% | 212,040 | -29.6% | 0.00% | – |
Q2 2017 | $822,000 | -75.7% | 300,986 | -70.6% | 0.00% | -100.0% |
Q1 2017 | $3,386,000 | +19.7% | 1,023,098 | -13.9% | 0.00% | +100.0% |
Q4 2016 | $2,829,000 | -46.2% | 1,188,442 | -17.0% | 0.00% | -66.7% |
Q3 2016 | $5,257,000 | +62.1% | 1,432,319 | -1.5% | 0.00% | +50.0% |
Q2 2016 | $3,243,000 | +2.1% | 1,454,251 | -4.8% | 0.00% | 0.0% |
Q1 2016 | $3,177,000 | -35.3% | 1,527,273 | -5.8% | 0.00% | -33.3% |
Q4 2015 | $4,911,000 | +9.0% | 1,620,821 | -11.2% | 0.00% | 0.0% |
Q3 2015 | $4,507,000 | -13.6% | 1,824,856 | +12.3% | 0.00% | 0.0% |
Q2 2015 | $5,215,000 | -9.8% | 1,624,817 | +0.3% | 0.00% | -25.0% |
Q1 2015 | $5,782,000 | +75.4% | 1,619,764 | +11.6% | 0.00% | +100.0% |
Q4 2014 | $3,296,000 | +10.9% | 1,452,050 | -5.3% | 0.00% | 0.0% |
Q3 2014 | $2,973,000 | -43.6% | 1,532,529 | +5.6% | 0.00% | -50.0% |
Q2 2014 | $5,267,000 | +35.9% | 1,451,074 | +45.2% | 0.00% | +33.3% |
Q1 2014 | $3,876,000 | +14.7% | 999,075 | -15.8% | 0.00% | 0.0% |
Q4 2013 | $3,380,000 | -7.6% | 1,186,129 | +16.1% | 0.00% | 0.0% |
Q3 2013 | $3,659,000 | +27.8% | 1,021,943 | +19.2% | 0.00% | 0.0% |
Q2 2013 | $2,863,000 | – | 857,227 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |